Immunotherapy after surgery proven effective in reducing disease spread in high risk early stage patients.
Australian researchers and patients were critical to trialling this breakthrough new treatment for advanced melanoma patients.
MIA has joined Sydney Health Partners, with a shared focus on more rapidly translating research evidence into patient benefit.
A promising young MIA researcher is conferred with University of Sydney PhD.
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
The 'Distinguished Alumni Award' from University of Tasmania honours the exceptional impact of his work around the world.
The 'Outstanding Research Award' recognises their life-saving discoveries transforming melanoma patient care.
The award recognises her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
New research shows routine skin checks by a health professional, plus checking your own skin, are vital in saving lives from melanoma.